InspireMD Inc Stock Nyse
Equities
US45779A3095
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
05-14 | Transcript : InspireMD, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | Earnings Flash (NSPR) INSPIREMD Posts Q1 Revenue $1.5M, vs. Street Est of $1.9M | MT |
Sales 2024 * | 7.09M 9.76M | Sales 2025 * | 14.65M 20.16M | Capitalization | 67.05M 92.29M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 9.45 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.58 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.64% |
Latest transcript on InspireMD Inc
Managers | Title | Age | Since |
---|---|---|---|
Marvin Slosman
CEO | Chief Executive Officer | 60 | 19-12-31 |
Craig Shore
DFI | Director of Finance/CFO | 62 | 11-03-30 |
Juan Rigla
CTO | Chief Tech/Sci/R&D Officer | - | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Roubin
BRD | Director/Board Member | 75 | 20-10-12 |
Marvin Slosman
CEO | Chief Executive Officer | 60 | 19-12-31 |
Thomas Kester
BRD | Director/Board Member | 77 | 16-09-05 |
1st Jan change | Capi. | |
---|---|---|
-2.26% | 187B | |
+2.05% | 110B | |
-1.31% | 69.54B | |
+14.65% | 46.37B | |
-6.69% | 46.05B | |
+7.97% | 42.54B | |
+18.60% | 30.72B | |
+16.92% | 25.62B | |
-6.87% | 23.32B |